Wall Street Associates’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-22,533
Closed -$2.04M 346
2015
Q2
$2.04M Sell
22,533
-859
-4% -$90.8K 0.19% 132
2015
Q1
$2.85M Sell
23,392
-1,116
-5% -$117K 0.27% 114
2014
Q4
$2.69M Sell
24,508
-175
-0.7% -$18.9K 0.26% 121
2014
Q3
$2.52M Sell
24,683
-3,017
-11% -$316K 0.26% 115
2014
Q2
$3.01M Buy
27,700
+192
+0.7% +$20.9K 0.26% 124
2014
Q1
$3.56M Sell
27,508
-309
-1% -$49.3K 0.29% 114
2013
Q4
$3.81M Buy
27,817
+1,567
+6% +$206K 0.31% 114
2013
Q3
$3.92M Buy
+26,250
New +$4.58M 0.37% 97

Other funds holding VSTM

Wall Street Associates's VSTM Position: Q3 2015 in Review

Wall Street Associates sold out of Verastem (VSTM) in Q3 2015, closing a stake of 22,533 shares — an estimated $2.04M sold.

Wall Street Associates first reported a position in VSTM in Q3 2013 and held it in 8 quarters. The position peaked at $3.92M in Q3 2013. 76 funds tracked by Wall St. Rank hold VSTM as of Q3 2015.

  • Wall Street Associates reported no remaining Verastem position as of Q3 2015 after selling out during the quarter.
  • Wall Street Associates sold 22,533 Verastem shares in Q3 2015, an estimated $2.04M.
  • Wall Street Associates first reported a position in Verastem in Q3 2013 and held it in 8 quarters.
  • Wall Street Associates's Verastem position peaked at $3.92M in Q3 2013.
  • 76 funds tracked by Wall St. Rank held Verastem as of Q3 2015.

Based on Wall Street Associates's 13F filing for Q3 2015, filed 12 Nov 2015.